Metamodix, Inc
3650 Annapolis Ln N Ste 130
Minneapolis, MN 55447
Metamodix, Inc., based in Minneapolis, MN, is committed to addressing the human and financial impacts of metabolic diseases. Their flagship product, the EndoSleeve, aims to provide a safer and more cost-effective treatment for individuals battling Type 2 Diabetes, obesity, and NASH.
Currently undergoing preliminary clinical evaluation outside the United States, the EndoSleeve is not yet approved for sale anywhere in the world. The information available reflects the company's dedication to advancing treatment technologies for metabolic conditions.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.